Aspen Aerogels (NYSE:ASPN – Get Free Report) issued its quarterly earnings results on Thursday. The construction company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.20, FiscalAI reports. The firm had revenue of $85.18 million during the quarter, compared to analysts’ expectations of $72.07 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%.
Here are the key takeaways from Aspen Aerogels’ conference call:
- Q3 results exceeded guidance: Revenue was $85.2 million and adjusted EBITDA was $19.8 million, with higher volumes lifting adjusted gross margin to 41%. Management said the quarter’s roughly 75% incremental EBITDA conversion was unusually high due to product mix and cost absorption, and expects a more typical 50%–60% going forward.
- European thermal-barrier business is scaling: Record Q3 revenue from seven OEMs across eight programs supports a 2026 revenue expectation near $30 million and a 2027 target of $50 million–$60 million. Management also cited recovering GM production, while its Q4 assumptions for GM are below the current industry forecast.
- Energy industrial demand remains strong: Aspen is targeting approximately 20% growth in 2026, citing robust LNG activity, completed subsea deliveries and a subsea project in hand for 2027. Management described LNG and broader energy-infrastructure investment as opportunities for further growth.
- New markets are beginning to contribute: Aspen recorded initial revenue from battery energy storage system evaluations and secured its first data-center infrastructure order for Q4. Both opportunities remain early-stage, though management sees potential for BESS revenue in 2027 and views data centers as a possible high-margin extension of its existing capabilities.
- East Providence disruption continues to weigh on results and cash flow: The staged restart is expected to be completed in the first half of 2027, with incident-related costs continuing in the meantime and insurance reimbursements still pending. Aspen ended Q3 with $146.5 million in cash and restricted cash and net cash just above $60 million.
Aspen Aerogels Stock Performance
Shares of ASPN traded down $0.25 during trading hours on Friday, reaching $4.91. 1,854,782 shares of the company’s stock traded hands, compared to its average volume of 849,016. Aspen Aerogels has a twelve month low of $2.30 and a twelve month high of $8.10. The business’s fifty day simple moving average is $5.23 and its two-hundred day simple moving average is $4.70. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. The firm has a market capitalization of $407.81 million, a price-to-earnings ratio of -3.11 and a beta of 3.06.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on ASPN shares. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays increased their price objective on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a research report on Tuesday, August 11th. Wall Street Zen raised Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. Roth Capital restated a “buy” rating and set a $7.75 price objective on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, September 21st. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $6.25.
Get Our Latest Research Report on Aspen Aerogels
Insider Buying and Selling
In other news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of the company’s stock in a transaction that occurred on Wednesday, September 23rd. The shares were sold at an average price of $4.73, for a total value of $58,086,414.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 2.96% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.
Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.
Featured Articles
- Five stocks we like better than Aspen Aerogels
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
